← Leaderboards
Manuela Sushnitha
Rice University
$120,560
Attributed
$120,560
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $43K · FY2018–20$50K$37.5K$25K$12.5K$0
'18
'19
'20
Funding mix
By agency
NIH$120,560 · 1
By mechanism
F31$120,560 · 1
Top collaborators
No co-investigators on record.
Most similar at Rice University
Same institution · by research overlap
- Omid Veiseh$5,498,436
- Jeffrey G Jacot$2,453,425
- Richard Alan Schwarz$1,933,400
- Ann M Gillenwater$6,129,088
- Rebecca Rae Richards-Kortum$39,668,312
Others in their field
Other Emerging Leaders on “Affinity”
- Bala Raja · Luminostics, Inc.$28,624,460
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$25,726,378
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$20,465,582
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
- Ashlin Bolton · Broad Institute, Inc.$19,699,069
- Timothy M Willson · University Of Cape Town$13,865,323
Research focus
AffinityAftercareBaseBiodistributionBiologicalBiologyBiomimeticsBloodBreast Cancer Cell LineBreast Cancer PatientCancer BiologyCancer Stem CellCancer SubtypesCellsCellular BiologyChemotherapyCombined Modality TherapyDiagnosisDoseDrug Delivery SystemsDrug ToxicityDrug VehicleEngineeringExperimental Study
Grant awards (3)
Targeting the JAK/STAT3 Pathway in Triple-Negative Breast Cancer Using Biomimetic Nanoparticles$35,060
F31 · FY2020 · CA · contact PI
Targeting the JAK/STAT3 Pathway in Triple-Negative Breast Cancer Using Biomimetic Nanoparticles$42,996
F31 · FY2019 · CA · contact PI
Targeting the JAK/STAT3 Pathway in Triple-Negative Breast Cancer Using Biomimetic Nanoparticles$42,504
F31 · FY2018 · CA · contact PI